F2R and nervous system disorder: Hence, it has been speculated that neural PAR1-inhibitors may prove suitable for the treatment of several neurological diseases associated with alterations in blood-brain barrier function and/or increased PAR1-activity (Boven et al., 2003; Ishida et al., 2006; Rosenberg, 2012).